Deficiency of p38α in macrophage ameliorates d-galactosamine/TNF-α-induced acute liver injury in mice

FEBS J. 2017 Dec;284(24):4200-4215. doi: 10.1111/febs.14294. Epub 2017 Nov 14.

Abstract

Growing evidence suggests that hepatic macrophages play an important role in tissue repair after liver injury by coordinating the induction and resolution of inflammation, removing apoptotic cells, and promoting hepatocyte proliferation. Understanding the role of macrophages in the pathogenesis of liver injury will help pave the way to future therapeutics. Here, we investigated whether macrophage p38α plays a regulatory role in the tissue repair following d-galactosamine (GalN)/tumor necrosis factor-α (TNF-α)-induced acute liver injury. We found that macrophage p38α-deficient mice displayed decreased mortality and relieved liver injury as evident from less apoptosis, accelerated regeneration, decreased granulocytes recruitment, monocytes infiltration, and cytokine production after GalN/TNF-α treatment. Mechanistically, we found that p38 signaling was activated by lipopolysaccharide/interferon-γ treatment but not by inteleukin-4 stimulation, while pharmaceutical inhibition of p38α induced a shift in polarization from M1 macrophages to M2 macrophages. Together, our results indicated that macrophage p38α signaling is involved in the pathogenesis of liver injury induced by GalN/TNF-α, and inhibition of p38α signaling in macrophage could ameliorate liver injury and accelerate regeneration, probably by promoting the polarization of macrophages from the M1 phenotype to the M2 phenotype.

Keywords: liver injury; macrophage polarization; p38α.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Differentiation / biosynthesis
  • Antigens, Differentiation / genetics
  • Cell Cycle Proteins / biosynthesis
  • Cell Cycle Proteins / genetics
  • Chemical and Drug Induced Liver Injury / enzymology*
  • Chemical and Drug Induced Liver Injury / etiology
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Cytokines / biosynthesis
  • Cytokines / genetics
  • Galactosamine / toxicity*
  • Hep G2 Cells
  • Hepatocytes / drug effects
  • Humans
  • Immunophenotyping
  • Interferon-gamma / pharmacology
  • Lethal Dose 50
  • Lipopolysaccharides / pharmacology
  • Liver Regeneration / drug effects
  • Liver Regeneration / physiology*
  • MAP Kinase Signaling System / drug effects
  • Macrophages / classification
  • Macrophages / enzymology*
  • Male
  • Mice
  • Mice, Knockout
  • Mitogen-Activated Protein Kinase 14 / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase 14 / deficiency*
  • Mitogen-Activated Protein Kinase 14 / physiology
  • Phosphorylation / drug effects
  • Protein Processing, Post-Translational / drug effects
  • RAW 264.7 Cells
  • Tumor Necrosis Factor-alpha / toxicity*

Substances

  • Antigens, Differentiation
  • Cell Cycle Proteins
  • Creb1 protein, mouse
  • Cyclic AMP Response Element-Binding Protein
  • Cytokines
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Galactosamine
  • Interferon-gamma
  • Mitogen-Activated Protein Kinase 14